who is developing retatrutide Is a new weight-loss drug

The forward-looking statements contained in this press release are made only as of May 20, 2026

Possible cross-contamination with milk and products thereof (including lactose), soy, crustaceans, fish, as well as gluten-containing grains and products thereof

Do not blow on the needle

Zepbound (tirzepatide) Zepbound is a dual GLP-1 and GIP receptor agonist medication

Bills like the Treat and Reduce Obesity Ac t would allow Part D to cover FDA-approved weight-loss drugs more broadly, but as of late 2025, no such law has passed.

If you are considering Peak Wellness, getting your own labs done through your primary care physician before starting is a smart move regardless of whether the platform requires it